نتایج جستجو برای: glucantime resistant

تعداد نتایج: 192640  

2014
Hossein MAHMOUDVAND Mojtaba SHAKIBAIE Razieh TAVAKOLI Sareh JAHANBAKHSH Iraj SHARIFI

BACKGROUND Sensitive and glucantime (MA) resistance Leishmania tropica are referred to those isolates, which are responsive, or non-responsive to one or two full courses of treatment by MA systematically and/or intra-lesionally, respectively. In this study, we evaluated the antileishmanial activity of biogenic selenium nanoparticles (Se NPs) alone and in combination with MA against sensitive an...

2013
Mohammad Bagher KHADEM ERFAN Mehdi MOHEBALI Elham KAZEMI-RAD Homa HAJJARAN GholamHossein EDRISSIAN Setareh MAMISHI Mojtaba SAFFARi Reza RAOOFIAN Mansour HEIDARI

BACKGROUND Pentavalent antimonials are the first line drugs for the treatment of leishmaniasis. Unresponsiveness of Leishmania spp. to antimonial drugs is a serious problem in some endemic areas. Investigations on molecular mechanisms involved in drug resistance are essential for monitoring and managing of the disease. Cal-cineurin is an essential protein phosphatase for number of signal transd...

Journal: :Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit 1992
A Fournet A A Barrios V Muñoz R Hocquemiller A Cavé

Plumbagin, 3,3'-biplumbagin and 8,8'-biplumbagin are naphthoquinones isolated by activity-directed fractionation from a Bolivian plant, Pera benensis, used in folk medicine as treatment of cutaneous leishmaniasis caused by Leishmania braziliensis. BALB/c mice were infected with L. mexicana or L. venezuelensis and treated 24 h after the parasitic infection with plumbagin (5 or 2.5 mg/kg/day), 3,...

جعفری, فریبا, عبداللهی, لطیفه, نیلفروش‌زاده, محمد علی,

Cutaneous leishmaniasis (CL) is an endemic parasitic disease of major health impact in many parts of the world and is caused by several species of the protozoan parasite Leishmania. Antimonial compounds (i.e glucantime and pentostam) are the first-line treatment for cutaneous leishmaniasis with emerging drug resistance as a problem. The control of Leishmania is further complicated by the emerge...

Journal: :The Korean journal of parasitology 2006
Ghassem Solgi Amina Kariminia Khossor Abdi Majid Darabi Behnaz Ghareghozloo

For treating Leishmania major infection in BALB/c mice, we used thalidomide in conjunction with glucantime. Groups of mice were challenged with 510(3) metacyclic promastigotes of L. major subcutaneously. A week after the challenge, drug treatment was started and continued for 12 days. Thalidomide was orally administrated 30 mg/kg/day and glucantime was administrated intraperitoneally (200 mg/kg...

Journal: :Annals of the Academy of Medicine, Singapore 2008
Giti Sadeghian Hengameh Ziaei Masumeh Sadeghi

INTRODUCTION Antimonial compounds are regarded as the treatment of choice for cutaneous leishmaniasis (CL). Systemic administration of these drugs has some side effects including cardio toxicity and electrocardiogram (EKG) changes. The objective of our study was to evaluate EKG changes in the patients with CL treated with systemic glucantime. MATERIALS AND METHODS One hundred and thirty-one p...

Journal: :BMC Complementary and Alternative Medicine 2007
Mohammad Ali Nilforoushzadeh Fariba Jaffary Shahram Moradi Roya Derakhshan Elaheh Haftbaradaran

BACKGROUND Leishmaniasis is an endemic disease in Iran. Although many treatments have been suggested for this disease, there hasn't been an effective and safe treatment yet. Regarding the healing effect of honey in the chronic ulcers and its reported therapeutic effect in cutaneous leishmaniasis, we performed a study to better evaluate the efficacy of honey in cutaneous leishmaniasis and its fi...

2003
Haideh Darabi Mohsen Abolhassani Mohammad H. Alimohammadian

The expansion of γδ T cells in patients with active cutaneous leishmaniasis, with or without glucantime therapy, was investigated. Twenty patients with local cutaneous leishmaniasis including glucantime-treated (n=10) and untreated (n=10) patients were selected. The controls were healthy individuals (n=10) living in endemic areas. Whole blood was obtained and the T cell subpopulations were anal...

2011
Nancy Saravia Olga Fernández Yira Díaz Clemencia Ovalle Sandra Muvdi Liliana Valderrama

Introduction Passive case detection and treatment constitute the principal and often the sole measure of control for dermal leishmaniasis in Central and South America yet pentavalent antimonials, the first line therapy, are often ineffective. Treatment failure is frequent and concerning in the management of cutaneous leishmaniasis in South America. Overall non-response is of the order of 24% ba...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید